Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interaction between haptoglobin genotype and glycemic variability on diabetic macroangiopathy: a population-based cross-sectional study.

Endocrine - 1 Nov 2023

Deng Zixuan, Wang Shiyun, Lu Jingyi, Zhang Rong, Zhang Lei, Lu Wei, Zhu Wei, Bao Yuqian, Zhou Jian, Hu Cheng

Abstract excerpt

PURPOSE: Haptoglobin (Hp) is a hemoglobin-binding protein that functions as an antioxidant in human plasma. It is reported that glycemic variability (GV) plays a key role in diabetes-related complications associated with impaired glucose metabolism and oxidative stress. Here we aim to investigate whether the effect of GV on diabetic macroangiopathy depends on Hp genotype in type 2 diabetes. METHODS: A number of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Glucose
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Complications

Share to Diabetes Mellitus, Type 2

Share to Genotype

Share to Glycated Hemoglobin

Share to Haptoglobins

Source

Identifiers

PMID: 37615814
DOI: 10.1007/s12020-023-03484-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interaction between haptoglobin genotype and glycemic variability on diabetic macroangiopathy: a population-based cross-sectional study.PMID 37615814Read ↗

Haptoglobin genotype and its role in diabetic cardiovascular disease.Semantic proximity Read ↗

Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients.Semantic proximity Read ↗

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy.Semantic proximity Read ↗

The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.Semantic proximity Read ↗

Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?Semantic proximity Read ↗

Hypothesis--haptoglobin genotype and diabetic nephropathy.Semantic proximity Read ↗

In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.Semantic proximity Read ↗

Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.Semantic proximity Read ↗

Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy.Semantic proximity Read ↗

Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.Semantic proximity Read ↗

Genetic determinants of variability in glycated hemoglobin (HbA(1c)) in humans: review of recent progress and prospects for use in diabetes care.Semantic proximity Read ↗

Association of hemoglobin glycation index and its interaction with obesity/family history of hypertension on hypertension risk: a community-based cross-sectional surveySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.